How to Get Rid of Technology Bias in Health Tech Marketing

BINEESH MATHEW | March 26, 2021 | 455 views

Health tech marketers tend to have a real bias problem. Everyone wants to believe that they have the best product available in the market, and are quite vocal about it on social platforms. But, are those the things your buyers want to know about your products?

The biggest mistake you can ever make in health tech marketing is leading it with a technology bias. It will immediately create a distance between your audience and you. If you are working in technology, you can easily assume that everyone knows what you are talking about all the time. You breathe and live your industry. And as the marketer of your company's products, it's your responsibility to go to prospects with your tech company’s message. In your personal life, too, you may talk to your friends and families about your work and realize they have no interest in what you say as they have no idea what you are talking about. That is because they are not immersed in your company or industry.

The same can happen in your health tech marketing process with your prospects and customers. Instead of focusing on their problems, if you lead with your technology solution and features of your products and company, you will lose them. It is vital to step back and see the bias you have in your company’s marketing initiatives.

 

How Technology Bias Affects Health Tech Marketing

The effects of technology bias in health tech marketing are strongest when the health tech marketer focuses more on technology, product, or company than the buyer's pain points. Customers do not want to know everything about your product. They probably want to know how your product can solve their issues. When approaching buyers with your product, this health tech marketing technology bias can have many adverse effects on the buying process.

Technology bias in health tech marketing will lead to failure to get the customers' trust. They feel you are just trying to sell your product by explaining your product's features rather than solving the customer's issues. Technology bias in health tech marketing also will result in a negative effect on brand performance. As a health tech marketer, you are wrong in assuming you can sell your products by boosting the company or products of the company. It will only result in losing the customer's trust if you are not considering the buyers' problems. If you are going on with the practice, it will eventually affect your brand's performance as buyers view you as not genuine.

This unfair practice of technology bias in health tech marketing will make you realize that you are losing the customers, even the existing ones. No buyer wants to hear more about the features or the technologies used in your products. They are focused on their issues and want to know how your product can solve those issues. Thus, as a health tech marketer, you may have to focus more on the customer pain points when approaching buyers; this will help you convert potential customers into clients.

 

How to Get Rid of Technology Bias and Improve Health Tech Sales

FPX Digital Transformation Study 2019 says that B2B companies have shifted their focus to customer experience from internal efficiency. Most of the respondents agree that they spend much of their digital transformation funds improving the customer experience.

An important way to implement a buyer-centric or customer-centric marketing approach is to remove bias about your product from your health tech marketing efforts. Mainly, this has to be removed from the messages you send out in the early stages of the buyer journey. However, making it practical is difficult as it is ingrained in how you write, speak, and present your company to external and internal audiences.

 

Here are some tips to get out of technology bias in health tech marketing and get closer to your customers.

 

Listen to Customers Clearly

Successful marketers excel not only in communicating but also in listening. It is impossible to create a message about your health tech product if you do not know what problem it can really solve. It will help if you take the time to know your prospects and customers. Do not let your mind wander thinking about which benefits and features you have to push in your health tech marketing.  Remain fully present in video, phone, and in-person meetings. That will help you find they have different problems, and you can solve them differently.

When you give importance to listening, you will not waste time and effort solving a problem that you think exists.  Instead, you will start developing buyer-centric health tech marketing messages that align with your business.

 

Don’t Assume Anything

You hate being in a room where people are talking about a subject you know nothing about. Your health tech buyers may have the same experience if you assume your customers know what you do and how they fit into your space.

That’s why it’s essential not to take a “features-first” approach in your marketing interactions. You understand your product's ins and outs, but your prospects don’t and are likely not ready for that. As an effective health tech marketing technique, before you assume anything, give them the complete picture of who you are.

 

Simplify the Message

A product-driven language full of jargon will make your brand unapproachable for your audience.  You can apply the old phrase here, “keep it simple stupid.” You have to position your technology as sophisticated and robust, not convoluted and tricky, through an effective health tech marketing process.

Your health tech marketing content should make sense to people both outside and inside your industry and company. Visitors of your website should not go for additional research to understand what you do precisely. It should be clear from your content. Thus, simplifying your content is essential.

 

Make Your Customer the Hero

The hero of your health tech marketing story is not you but your customer. After all, your customers in your industry work hard to deliver better service and results to their customers.

Your messages should position you as a mentor for your customers that provides technology support in the job of your customers to drive success. The “customer hero” approach should have a fundamental change in how you speak to your customers. The approach is not fully taken hold in the B2B health tech marketing space so far.

 

Share Real World Stories

One of the most practical ways to eliminate technology bias from your health tech marketing is to talk more about your customers and less about your products and company. You have to show you have the purpose of bringing in a fundamental change in your industry that enhances the day-to-day business lives of people and not just sell great technology.

Testimonials and customer case studies help a lot in shaping your brand story. Using them, narratives can be created about your customers' journey after and before using your technology. Rather than detailing the benefits and features of technology, narratives highlight the platform's tangible business value for real people in businesses.

 

Final Word

Technology brings a change in companies, and most people do not accept changes so quickly. It is because the change pushes people to do things differently by moving beyond their comfort zones.

As part of health tech marketing, your job is not to make this change terrifying, but compelling for your buyers. This will happen only when you take your technology out of your head and start focusing on your clients' requirements, problems they face, and what exactly they need from you. It will then surely make you put your product and technology bias aside. And you will be capable of effectively executing your health tech marketing initiatives.

 

Frequently Asked Questions

 

How does health tech marketing become effective?

Effective health tech marketing is essential to reach out to potential clients and grab their attention. Health tech marketing becomes effective only when the marketer focuses on the requirements of the clients rather than on the features of the product or company. 

 

What is technology bias in marketing?

Technology bias in marketing is focusing much on your product or technology when you market a technology product to your prospects. Getting rid of this bias will make you attract more clients and successful in your marketing.

 

How to get rid of technology bias in health tech marketing?

Technology bias in your health tech marketing makes the customers put a distance from you. The best way to get rid of it is to make the customer the hero of your marketing messages by focusing on their issues.

Spotlight

Vara

Better breast cancer screening should be a universal offering to every woman in the world. Vara’s AI-powered software platform, created with screening radiologists in Germany,

OTHER ARTICLES
HEALTH TECHNOLOGY

3 Key Considerations in Cloud Security for Healthcare Organizations

Article | July 19, 2022

With medical system consolidation and increasing numbers of medical records created, the need for digital access and storage is gaining steam. Digitizing records allows clinicians to improve accuracy and decrease redundant testing and studies, as well as reduce treatment delays. Greater availability of digitized records has other perks too. With vast amounts of accessible medical data, researchers can move public health studies forward, also potentially improving care and treatment of individual patients. As a result, cloud storage is taking off, though healthcare organizations are adopting it more slowly than other industries. According to a 2019 Nutanix report, 71% of healthcare organizations using cloud were considered the least mature – relative beginners – in that they were using fewer cloud services. Compare that figure to finance or retail, where 13% and 15% respectively were beginners. However, that is changing.

Read More
HEALTH TECHNOLOGY

Advanced Healthcare Supply Chains: Why It’s All in the Data

Article | August 12, 2022

During the past decade, the healthcare industry has undergone an unprecedented technological transformation. The industry, once defined by manual processes, has moved squarely into the digital age. As patients, we’ve all become accustomed to seeing physicians as well as clinical staff use laptops during office visits. And behind the scenes, hospitals and health networks have made substantial investments in financial and HR systems, among others. One of the more significant digital advancements has been the industry’s focus on applying greater levels of automation to supply chain processes. In doing so, provider and supplier organizations have improved the efficiency of their supply chains, driven out millions of dollars in cost and waste, all while keeping patient care front and center.

Read More
HEALTH TECHNOLOGY

Artificial Intelligence Adoption in Healthcare

Article | August 29, 2022

Artificial intelligence (AI) – long an impactful technology in other industries – is in the midst of rapid adoption across the healthcare industry. What was once seen as having great potential is now making its way to real-world implementation, driving improvements in care through enhanced clinical decision support, empowering payers, providers and healthcare organizations across the ecosystem with actionable insight. Patient-generated behavioral data is becoming increasingly common for care management. Smart gadgets such as Fitbits, smartphones and other wearable sensors collect patients’ data, helping patients and physicians better understand habits and set realistic healthcare goals.

Read More

Digital Health Democratizes Precision Medicine to Improve Population Health

Article | February 10, 2020

By definition, precision medicine treats the individual while public health focuses on population-level interventions. While public health and precision medicine efforts overlap, some experts argue that precision medicine advancements fall short of public health goals due to their underemphasis on scalability and accessibility. Digital health can help reconcile this conflict by promoting precision medicine’s goal of delivering the right treatment to the right patient at the right time while improving health equity through scalable, accessible solutions.

Read More

Spotlight

Vara

Better breast cancer screening should be a universal offering to every woman in the world. Vara’s AI-powered software platform, created with screening radiologists in Germany,

Related News

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Rhythmlink Announces Investment Partnership With Graham Partners

Rhythmlink | March 20, 2023

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses. As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023. “We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” said Regan. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics.” This new relationship with Graham follows Rhythmlink’s extremely successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices. Joe Straczek, COO and CFO for Rhythmlink, spoke on the success of this relationship. “Our partnership with New Heritage was extremely beneficial,” said Straczek. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.” Rhythmlink sells a full line of consumable neurodiagnostic devices for Critical Care, electroencephalography, intraoperative neuromonitoring, the ER and ICU, and long-term epilepsy monitoring. About Rhythmlink Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by transforming medical device technology that links patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services. About Graham Partners Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions, and disruptions to traditional end markets. Graham Partners can offer control or minority capital solutions and typically targets companies with EBITDA up to $50 million. Since the firm's founding in 1988 by Steven Graham, Graham Partners has closed over 150 acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham Partners funds together with Graham-led co-investments totals approximately $4.0 billion as of December 31, 2022, which differs from Graham’s Regulatory Assets Under Management of approximately $2.2 billion as of December 31, 2022. Investors include high-net-worth individuals, college and university endowments, foundations, public and private pension plans, funds-of-funds, and other institutional investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating Graham Partners Inc. businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.

Read More

DIGITAL HEALTHCARE, HEALTHCARE ANALYTICS

PointClickCare Advances the Transition Toward Value-Based Care with Acquisition of Patient Pattern

PointClickCare | March 17, 2023

PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, today announced the acquisition of Patient Pattern. The combination of PointClickCare and Patient Pattern will further the companies' shared vision of enabling better care and outcomes for high-needs populations and provide care teams with the solutions they need to successfully operate at the top of their license. The shift to value-based care continues to accelerate each year, especially as providers are increasingly taking on more risk. According to a recent McKinsey and Company study, the number of patients treated within the value-based care landscape could roughly double in the next five years. Institutional Special Needs Plans (I-SNPs), demonstrate the enormous potential of aligned value-based care models. “Senior care providers need support as they navigate new models of care and ultimately take on more risk-bearing responsibilities, inclusive of technology that helps them deliver exceptional care, particularly to high-needs populations,” said Travis Palmquist, Senior Vice President and General Manager of Senior Care at PointClickCare. “As our customers continue to embrace value-based care and see the success of this model, we are excited to deploy Patient Pattern’s care management platform. Care models will continue to evolve, and this strategic investment is another example of our commitment to helping our customers thrive in this evolving market, specifically, the opportunity to succeed with this shift to risk.” Since its inception, PointClickCare has invested in innovation across the care continuum to close gaps in healthcare delivery through its rich and expansive insights. PointClickCare and Patient Pattern’s combined offerings provide a mechanism to adopt and succeed in risk-bearing arrangements without having to use multiple fragmented solutions. Through this acquisition, PointClickCare will further enable providers to take a comprehensive approach to frailty, ultimately providing better overall care planning. “Over the past ten years, we’ve worked hard to integrate a care management philosophy and capabilities directly into our EHR,” said Dr. Steven Buslovich, co-founder and Chief Executive Officer at Patient Pattern. “We’re thrilled to join forces with PointClickCare as we march toward our collective goal of helping clinicians better predict and document risk, close care gaps, and improve patient outcomes. The marriage of an integrated care management platform with population health data will prove to be a major differentiator for us.” Goodwin Procter LLP served as legal advisor and PricewaterhouseCoopers LLP served as tax and accounting advisor to PointClickCare. Nemphos Braue LLC served as legal advisor to Patient Pattern. Terms of the transaction were not disclosed. About PointClickCare PointClickCare is a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey. More than 27,000 long‐term and post‐acute care providers, over 2,800 hospitals and 2,000 ambulatory clinics, every major U.S. health plan across the U.S, and over 75 state and government agencies use PointClickCare, enabling care collaboration and value‐based care delivery for millions across North America.

Read More

HEALTH TECHNOLOGY

Netherlands Healthcare Extends Sectra Contract, Adopts Cloud Service

Sectra | March 16, 2023

Sectra, a global healthcare IT leader, informed on March 15, 2023, that it has renewed its contract with Dutch hospital Zuyderland for another ten years. Sectra One Cloud, a cloud-based version of its enterprise imaging product, is included in the arrangement, offering Zuyderland a scalable, secure, and professionally managed service. With Sectra managing the infrastructure, healthcare practitioners can focus on delivering exceptional patient care. Ralph Berendsen, Medical Physicist at Zuyderland Medical Center, stated, "Our current infrastructure needs to be replaced, giving us the perfect opportunity to move over to Sectra's cloud solution." He added, "We've been a happy customer of Sectra for many years, so letting them take full responsibility for our IT operations was an easy choice. Moving to the cloud will reduce our IT burden, giving us the time to focus on our users." (Source – Cision PR Newswire) The radiology, nuclear medicine, and orthopedic departments of Zuyderland Medical Center are in Sittard-Geleen and Heerlen. The company, which has been using Sectra's solution since 2017, will be the first Dutch company to adopt Sectra One Cloud, developed in Microsoft Azure. Peter Osinga, Managing Director, Sectra Benelux and DACH, remarked, "Many healthcare providers are currently facing challenges when it comes to high workloads and a lack of resources. In addition, secure communication and sharing of sensitive data has never been more important. As a result, we are seeing increasing interest in cloud services." He added, "I'm happy that Zuyderland remains satisfied with us as their technology provider, and I am proud of being trusted to manage their IT infrastructure." (Source – Cision PR Newswire) This contract, which includes radiology, breast imaging, and orthopedics, was finalized in February 2023. About Sectra Sectra strives to promote a better and more secure society by assisting health systems worldwide in improving care efficiency and helping European authorities and defense forces preserve sensitive information. Founded in 1978, the company's headquarters are in Linköping (Sweden). With global distribution partners, it conducts direct sales in 19 countries.

Read More

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Rhythmlink Announces Investment Partnership With Graham Partners

Rhythmlink | March 20, 2023

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses. As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023. “We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” said Regan. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics.” This new relationship with Graham follows Rhythmlink’s extremely successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices. Joe Straczek, COO and CFO for Rhythmlink, spoke on the success of this relationship. “Our partnership with New Heritage was extremely beneficial,” said Straczek. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.” Rhythmlink sells a full line of consumable neurodiagnostic devices for Critical Care, electroencephalography, intraoperative neuromonitoring, the ER and ICU, and long-term epilepsy monitoring. About Rhythmlink Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by transforming medical device technology that links patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services. About Graham Partners Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions, and disruptions to traditional end markets. Graham Partners can offer control or minority capital solutions and typically targets companies with EBITDA up to $50 million. Since the firm's founding in 1988 by Steven Graham, Graham Partners has closed over 150 acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham Partners funds together with Graham-led co-investments totals approximately $4.0 billion as of December 31, 2022, which differs from Graham’s Regulatory Assets Under Management of approximately $2.2 billion as of December 31, 2022. Investors include high-net-worth individuals, college and university endowments, foundations, public and private pension plans, funds-of-funds, and other institutional investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating Graham Partners Inc. businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.

Read More

DIGITAL HEALTHCARE, HEALTHCARE ANALYTICS

PointClickCare Advances the Transition Toward Value-Based Care with Acquisition of Patient Pattern

PointClickCare | March 17, 2023

PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, today announced the acquisition of Patient Pattern. The combination of PointClickCare and Patient Pattern will further the companies' shared vision of enabling better care and outcomes for high-needs populations and provide care teams with the solutions they need to successfully operate at the top of their license. The shift to value-based care continues to accelerate each year, especially as providers are increasingly taking on more risk. According to a recent McKinsey and Company study, the number of patients treated within the value-based care landscape could roughly double in the next five years. Institutional Special Needs Plans (I-SNPs), demonstrate the enormous potential of aligned value-based care models. “Senior care providers need support as they navigate new models of care and ultimately take on more risk-bearing responsibilities, inclusive of technology that helps them deliver exceptional care, particularly to high-needs populations,” said Travis Palmquist, Senior Vice President and General Manager of Senior Care at PointClickCare. “As our customers continue to embrace value-based care and see the success of this model, we are excited to deploy Patient Pattern’s care management platform. Care models will continue to evolve, and this strategic investment is another example of our commitment to helping our customers thrive in this evolving market, specifically, the opportunity to succeed with this shift to risk.” Since its inception, PointClickCare has invested in innovation across the care continuum to close gaps in healthcare delivery through its rich and expansive insights. PointClickCare and Patient Pattern’s combined offerings provide a mechanism to adopt and succeed in risk-bearing arrangements without having to use multiple fragmented solutions. Through this acquisition, PointClickCare will further enable providers to take a comprehensive approach to frailty, ultimately providing better overall care planning. “Over the past ten years, we’ve worked hard to integrate a care management philosophy and capabilities directly into our EHR,” said Dr. Steven Buslovich, co-founder and Chief Executive Officer at Patient Pattern. “We’re thrilled to join forces with PointClickCare as we march toward our collective goal of helping clinicians better predict and document risk, close care gaps, and improve patient outcomes. The marriage of an integrated care management platform with population health data will prove to be a major differentiator for us.” Goodwin Procter LLP served as legal advisor and PricewaterhouseCoopers LLP served as tax and accounting advisor to PointClickCare. Nemphos Braue LLC served as legal advisor to Patient Pattern. Terms of the transaction were not disclosed. About PointClickCare PointClickCare is a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey. More than 27,000 long‐term and post‐acute care providers, over 2,800 hospitals and 2,000 ambulatory clinics, every major U.S. health plan across the U.S, and over 75 state and government agencies use PointClickCare, enabling care collaboration and value‐based care delivery for millions across North America.

Read More

HEALTH TECHNOLOGY

Netherlands Healthcare Extends Sectra Contract, Adopts Cloud Service

Sectra | March 16, 2023

Sectra, a global healthcare IT leader, informed on March 15, 2023, that it has renewed its contract with Dutch hospital Zuyderland for another ten years. Sectra One Cloud, a cloud-based version of its enterprise imaging product, is included in the arrangement, offering Zuyderland a scalable, secure, and professionally managed service. With Sectra managing the infrastructure, healthcare practitioners can focus on delivering exceptional patient care. Ralph Berendsen, Medical Physicist at Zuyderland Medical Center, stated, "Our current infrastructure needs to be replaced, giving us the perfect opportunity to move over to Sectra's cloud solution." He added, "We've been a happy customer of Sectra for many years, so letting them take full responsibility for our IT operations was an easy choice. Moving to the cloud will reduce our IT burden, giving us the time to focus on our users." (Source – Cision PR Newswire) The radiology, nuclear medicine, and orthopedic departments of Zuyderland Medical Center are in Sittard-Geleen and Heerlen. The company, which has been using Sectra's solution since 2017, will be the first Dutch company to adopt Sectra One Cloud, developed in Microsoft Azure. Peter Osinga, Managing Director, Sectra Benelux and DACH, remarked, "Many healthcare providers are currently facing challenges when it comes to high workloads and a lack of resources. In addition, secure communication and sharing of sensitive data has never been more important. As a result, we are seeing increasing interest in cloud services." He added, "I'm happy that Zuyderland remains satisfied with us as their technology provider, and I am proud of being trusted to manage their IT infrastructure." (Source – Cision PR Newswire) This contract, which includes radiology, breast imaging, and orthopedics, was finalized in February 2023. About Sectra Sectra strives to promote a better and more secure society by assisting health systems worldwide in improving care efficiency and helping European authorities and defense forces preserve sensitive information. Founded in 1978, the company's headquarters are in Linköping (Sweden). With global distribution partners, it conducts direct sales in 19 countries.

Read More

Events